T. Rowe Price Associates »

Bridgebio Oncology Therapeut shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.9M 438k 8.95
2025-12-31 $10M 803k 12.52
2025-09-30 $10M 885k 11.58

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Alphabet
EcoR1 Capital
Wellington Management Company
Enavate Sciences GP
Citadel Advisors
Novo A/S
BlackRock
Laurion Capital Management
Armistice Capital
Aisling Capital Management
Paradigm Biocapital Advisors
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut